Arcutis Biotherapeutics Inc ARQT

$26.22 -0.36 (-1.35%)

Valuation

Market cap
3,340,894,000
Revenue TTM
$376,070,000
Net income TTM
$-16,140,000
PE ratio
116.62
Forward PE
58.31
Profit margin
-4.29%
Debt to equity
0.49

Trading

Volume
1,540,547
Avg volume
2,525,576
Day's range
$25.97 – $26.82
Shares out
125,692,000
Stochastic %K
75%
Beta
1.57
Analysts
Strong Sell
Price target
$37.00

Price

Company profile

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selec...

Show more

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Industry
Biotechnology
Sector
Healthcare
Phone
805 418 5006
Website
https://www.arcutis.com
Address
3027 Townsgate Road, Suite 300, Westlake Village, United States

Latest news

Stocktwits

AC_TRADER Oct 11, 7:14 AM
$ARQT key levels 🎯 Built with @TrendSpider. https://share.trendspider.com/chart/ARQT/75943hlw8c
0 replies
BiltmoreAz Oct 9, 8:06 PM
$ARQT Nice Day. Be great if we can grind our way up next week instead of down!
0 replies
johnnyutah007 Oct 9, 5:29 PM
$ARQT 💰
0 replies
Jaaqs Oct 9, 3:50 PM
$ARQT back down to $23 Tuesday
4 replies
johnnyutah007 Oct 9, 2:36 PM
$ARQT 👀
0 replies
Bio_investor_ Oct 9, 2:07 PM
$ARQT $IBB $XBI based on today's data. here is the latest PT target. https://finance.yahoo.com/healthcare/articles/arcutis-presents-zoryve-roflumilast-data-120000064.html
0 replies
Rhody27 Oct 8, 7:06 PM
$ARQT the shorts are looking for suckers to sell.
0 replies
Longboardsoul Oct 8, 3:10 PM
$ARQT Wacky Watanabe hurting investors yet again
0 replies